Securities Fraud Investigation Into Grail, Inc. (GRAL) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of Grail, Inc. (“Grail” or the “Company”) (NASDAQ: GRAL) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON GRAIL, INC. (GRAL), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.
What Is The Investigation About?
On February 19, 2026, Grail announced that the “primary endpoint of statistically significant Stage III-IV [cancer] reduction was not observed” in its NHS-Galleri Trial due, in part, to “probably need[ing] a longer follow-up time to be able to [compare the study arms] adequately.”
